Reshape Lifesciences Inc.
13F holders, Q3 2025 (September 30)1holders −3
1new positions
4sold out
$5.18avg. 13F price*
At the end of Q3 2025, 1 institutions reported holding Reshape Lifesciences Inc. in their 13F filings, down 3 from Q2 2025. 1 opened new positions and 4 sold out. The largest holder was NorthCoast Asset Management LLC ($76K).
- Company
- Reshape Lifesciences Inc.
- CUSIP
- 76090R408
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $76K |
| Exits | 4 | $47K |
All 13F filers, Q2 2025 → Q3 2025: 14,640 shares bought and 19,060 shares sold, net −4,420 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| NorthCoast Asset Management LLC | 0.00% | New | 14,640 | $76K |
"% of holder's portfolio" is RESHAPE LIFESCIENCES INC's weight in each manager's 13F, not the share of Reshape Lifesciences Inc. the manager owns.